Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Aytu BioPharma, Inc. AYTU

Full chart Compare
Set alert

Price alert · AYTU

All alert types
1.83 USD +0.02 (+1.10%)

At closeNov 6, 2026, 4:00 PM EST

1.83 0.00 0.00%

After hours · Nov 6, 4:00 PM ET

1.77 Day range 1.95
1.75 52-week range 3.07
YTD
-29.62%
1 year
-14.49%

Financial health

Altman Z-Score

-4.23 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 5

Valuation

P/E -1.9×
FY 2017: -0.2×FY 2018: -0.3×FY 2019: -0.3×FY 2020: -4.7×FY 2021: -1.4×FY 2022: -0.2×FY 2023: -0.3×FY 2024: -1.0×FY 2025: -1.0×FY 2026: -1.9×
FY 2017 5y median -1.0× FY 2026
P/S 0.5×
FY 2017: 1.7×FY 2018: 0.9×FY 2019: 2.0×FY 2020: 2.4×FY 2021: 1.3×FY 2022: 0.2×FY 2023: 0.0×FY 2024: 0.2×FY 2025: 0.2×FY 2026: 0.5×
FY 2017 5y median 0.2× FY 2026
P/B 0.8×
FY 2017: 1.4×FY 2018: 0.3×FY 2019: 2.1×FY 2020: 0.7×FY 2021: 0.6×FY 2022: 0.5×FY 2023: 0.1×FY 2024: 0.6×FY 2025: 0.7×FY 2026: 0.8×
FY 2017 5y median 0.6× FY 2026
P/FCF 8.1×
FY 2017: -0.4×FY 2018: -0.2×FY 2019: -1.1×FY 2020: -2.3×FY 2021: -3.2×FY 2022: -0.7×FY 2023: -1.0×FY 2024: -9.2×FY 2025: -2.7×FY 2026: 8.1×
FY 2017 5y median -1.0× FY 2026
EV/EBITDA -4.2×
FY 2017: -0.3×FY 2018: 0.2×FY 2019: -0.3×FY 2020: -1.6×FY 2021: -2.3×FY 2022: -0.7×FY 2023: -3.9×FY 2024: 8.7×FY 2025: -1.2×FY 2026: -4.2×
FY 2017 5y median -1.2× FY 2026
EV/Sales 0.3×
FY 2017: 1.5×FY 2018: -1.0×FY 2019: 0.5×FY 2020: 0.7×FY 2021: 1.0×FY 2022: 0.2×FY 2023: 0.1×FY 2024: 0.2×FY 2025: 0.1×FY 2026: 0.3×
FY 2017 5y median 0.2× FY 2026
FCF Yield 12.3%
FY 2017: -252.4%FY 2018: -462.7%FY 2019: -92.8%FY 2020: -43.4%FY 2021: -30.8%FY 2022: -142.1%FY 2023: -96.0%FY 2024: -10.9%FY 2025: -37.7%FY 2026: 12.3%
FY 2017 5y median -37.7% FY 2026

Profitability

Gross Margin 64.0%
FY 2017: 56.0%FY 2018: 44.0%FY 2019: 69.9%FY 2020: 70.0%FY 2021: 44.5%FY 2022: 52.0%FY 2023: 62.0%FY 2024: 75.3%FY 2025: 69.0%FY 2026: 64.0%
FY 2017 5y median 64.0% FY 2026
Operating Margin -14.4%
FY 2017: -624.7%FY 2018: -538.3%FY 2019: -230.1%FY 2020: -76.5%FY 2021: -89.7%FY 2022: -113.7%FY 2023: -15.9%FY 2024: -2.4%FY 2025: -11.8%FY 2026: -14.4%
FY 2017 5y median -14.4% FY 2026
Net Margin -24.8%
FY 2017: -698.7%FY 2018: -278.4%FY 2019: -644.3%FY 2020: -49.3%FY 2021: -88.8%FY 2022: -112.5%FY 2023: -15.9%FY 2024: -24.3%FY 2025: -20.4%FY 2026: -24.8%
FY 2017 5y median -24.3% FY 2026
ROE -40.4%
FY 2017: -562.7%FY 2018: -75.9%FY 2019: -665.5%FY 2020: -14.3%FY 2021: -42.4%FY 2022: -245.5%FY 2023: -43.3%FY 2024: -57.2%FY 2025: -71.5%FY 2026: -40.4%
FY 2017 5y median -57.2% FY 2026
ROIC -14.2%
FY 2017: -176.7%FY 2018: -111.5%FY 2019: -57.4%FY 2020: -16.8%FY 2021: -32.4%FY 2022: -142.4%FY 2023: -22.0%FY 2024: -2.6%FY 2025: -10.8%FY 2026: -14.2%
FY 2017 5y median -14.2% FY 2026
ROA -13.6%
FY 2017: -150.1%FY 2018: -48.4%FY 2019: -135.8%FY 2020: -8.9%FY 2021: -21.9%FY 2022: -79.0%FY 2023: -12.4%FY 2024: -13.3%FY 2025: -10.9%FY 2026: -13.6%
FY 2017 5y median -13.3% FY 2026

Growth (YoY)

Revenue -13.3%
FY 2017: 25.7%FY 2018: 13.6%FY 2019: 100.0%FY 2020: 277.5%FY 2021: 137.5%FY 2022: 47.3%FY 2023: 11.1%FY 2024: -39.3%FY 2025: 1.8%FY 2026: -13.3%
FY 2017 FY 2026
Operating Income -6.2%
FY 2017: 7.3%FY 2018: 2.1%FY 2019: 14.5%FY 2020: -25.4%FY 2021: -178.6%FY 2022: -86.7%FY 2023: 84.5%FY 2024: 90.7%FY 2025: -392.0%FY 2026: -6.2%
FY 2017 FY 2026
EPS (diluted) 46.3%
FY 2017: 85.1%FY 2018: 98.4%FY 2019: 60.5%FY 2020: 95.0%FY 2021: -15.6%FY 2022: -6.3%FY 2023: 93.1%FY 2024: 44.0%FY 2025: 24.5%FY 2026: 46.3%
FY 2017 FY 2026
Free Cash Flow 163.0%
FY 2017: -8.0%FY 2018: -14.9%FY 2019: 13.3%FY 2020: -104.3%FY 2021: 8.5%FY 2022: -11.0%FY 2023: 82.2%FY 2024: 66.5%FY 2025: -200.8%FY 2026: 163.0%
FY 2017 FY 2026

Financial Health

Current Ratio 1.1×
FY 2017: 0.8×FY 2018: 2.8×FY 2019: 2.9×FY 2020: 2.6×FY 2021: 1.0×FY 2022: 0.9×FY 2023: 1.1×FY 2024: 1.0×FY 2025: 1.3×FY 2026: 1.1×
FY 2017 5y median 1.1× FY 2026
Quick Ratio 1.0×
FY 2017: 0.5×FY 2018: 2.4×FY 2019: 2.6×FY 2020: 2.3×FY 2021: 0.8×FY 2022: 0.8×FY 2023: 0.9×FY 2024: 0.8×FY 2025: 1.1×FY 2026: 1.0×
FY 2017 5y median 0.9× FY 2026
Debt / Equity 0.5×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.2×FY 2022: 0.4×FY 2023: 0.8×FY 2024: 0.6×FY 2025: 1.2×FY 2026: 0.5×
FY 2017 5y median 0.6× FY 2026
Net Debt / EBITDA 1.9×
FY 2017: 0.1×FY 2018: 0.5×FY 2019: 0.8×FY 2020: 3.8×FY 2021: 0.6×FY 2022: 0.0×FY 2023: -2.3×FY 2024: -2.6×FY 2025: 1.7×FY 2026: 1.9×
FY 2017 5y median 0.0× FY 2026
Interest Coverage 4.4×
FY 2017: -7.9×FY 2018: -26.3×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -0.7×FY 2023: -3.4×FY 2024: -0.3×FY 2025: -2.1×FY 2026: 4.4×
FY 2017 5y median -0.7× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-06-30